Mpox containment strategies in China, 2022–2023: from preparedness to legal management

作者：Weijing Shang, Jun Yan, Hongbin Zhang, Wannian Liang, Jue Liu, Min Liu · 发表于：BMJ Global Health · 年份：2025 · DOI：10.1136/bmjgh-2025-019279 · 被引用次数：3 · 研究领域：Poxvirus research and outbreaks、Bacillus and Francisella bacterial research、Herpesvirus Infections and Treatments

WHO declared mpox a Public Health Emergency of International Concern on 23 July 2022. China experienced the first imported case in September 2022, the first local case in May 2023, indigenous clustered outbreaks in June to August 2023 and finally has achieved routine management since September 2023. We designed a conceptual framework through literature review and theoretical underpinnings according to the risk management theory and Chinese mpox control practice, with the strategy and measures evolution of the mpox control in China over time from the stages of risk preparedness, emergency response and management, to routine report and management. Overall, China proactively takes strategies and measures ranging from risk preparedness to emergency response of imported cases, and finally controls the cross-border importation and local outbreaks of mpox. Notably, risk management was performed in the whole process of mpox response through HIV/AIDS service system. The imported case in September 2022 did not cause local transmission or aggregated outbreaks. The indigenous cases and clustered outbreaks in June 2023 did not result in three-generation transmission. Since September 2023, less than 100 cases per month and zero aggregated outbreaks were reported nationwide. As of 31 December 2023, the cumulative incidence per million population in China (1.202) was much lower than that in some European and American countries, such as Spain (161.780), Germany (45.633) and the USA (93.340). ...